Hacker News new | ask | show | jobs
by canucker2016 177 days ago
from the linked drug trial article, https://www.nejm.org/doi/full/10.1056/NEJMoa2500969:

  Gastrointestinal adverse events were more common with oral semaglutide than with placebo (74.0% vs. 42.2%).
That placebo value seems high (42.2%), given it's just a placebo (sugar pill?).
2 comments

As someone who almost died of (unrelated) gastroparesis: be absolutely sure you need this drug.
The placebo effect is shockingly strong. 30-50% report subjective benefits with placebo. Makes sense that about the same would report subjective side effects.